E1 is the DNA replication origin recognition protein for bovine papillomavirus (BPV), and it carries out enzymatic functions required for initiation of viral DNA replication. Cellular mechanisms likely play a role in regulating BPV DNA replication. We are investigating the role of phosphorylation of E1 on viral replication in vivo and on E1 activity in vitro. Serine 109 is a phosphoacceptor in vivo and is targeted by protein kinase A and protein kinase C in vitro. A viral genome carrying a serine 109 to alanine mutation replicates more efficiently than wild-type in vivo in a transient replication assay. Furthermore, purified mutant protein, while having wild-type levels of ATPase activity, is able to bind more origin-containing DNA than wild-type E1. Phosphorylation therefore appears to play a selective role in modulating a specific E1 function during viral DNA replication.
INTRODUCTION
. Recent work by a number of labs has elucidated details of the mechanism of viral DNA Papillomaviruses infect epithelial cells of a variety of replication in vivo and in vitro (Muller et al., 1994 ; Sanvertebrate hosts. Their unique infectious cycle makes tucci et al., 1990; Seo et al., 1993; Ustav et al., 1993 Ustav et al., , 1991 ; them a useful model system for a variety of cellular pro- Ustav and Stenlund, 1991; Yang et al., 1991 Yang et al., , 1991a Yang et al., , 1993 . cesses, including DNA replication. The bovine papilloReplication of papillomavirus DNA in virally transformed mavirus type-1 (BPV) genome is a double-stranded circuor transiently transfected cells requires three viral comlar DNA molecule, 7946 base pairs (bp) in length. In ponents: a cis-acting origin sequence and two viral proinfected cells, this DNA is complexed with cellular histeins, E1 and E2 (Ustav et al., 1993 (Ustav et al., , 1991 ; Ustav and tones to form a viral ''mini-chromosome. '' Stenlund, 1991; Winokur and McBride, 1992) . The miniThe natural course of papillomavirus infection requires mum functional viral replication origin contains binding entry of infectious virions into the basal cells of the episites for both E1 and E2 proteins, as well as an A/T-rich thelium, establishing a latent infection (Shah and Howley, domain. The E2 transactivator and its repressor deriva-1990). In the basal cells, the viral DNA is maintained as tives are responsible for regulating viral transcription. an extrachromosomal episome, expressing viral genes E2 also forms a complex with E1; its role in viral DNA required for the maintenance of the viral DNA in the replication is believed to be one of enhancing the recruitundifferentiated cell. As basal cells divide, some of the ment and binding of E1 to its target site in the replication daughter cells migrate toward the surface of the epitheorigin Mohr et al., 1990; Yang et al., lium , following a differentiation pathway. Only in the su-1991). One model for initiation of viral DNA replication prabasal granular layer is the viral genome amplified to requires the assembly of E1 at the origin, followed by high copy number, coordinated with expression of genes distortion of the DNA at the A/T rich sequence. E1 helirequired for assembly of new infectious virions (Howley, case activity then initiates unwinding of the DNA. Cellular 1990; Stoler et al., 1992) .
replication proteins are recruited to the replication origin, In latently infected basal cells and in tissue culture, forming an active replication fork complex. This model the viral genome is maintained at a relatively constant is consistent with known functions of the E1 protein (Gilcopy number of 50 to 200 copies per cell. This maintelette et al., 1994; MacPherson et al., 1994; Park et al. , nance is accomplished by replicating the resident viral 1994; Seo et al., 1993; Yang et al., 1993) . genomes an average of once per cell cycle. Viral DNA In vitro, BPV DNA replication can occur in the absence replication occurs in the S phase of the cell cycle in of E2, however E2 greatly stimulates replication activity, synchrony with cellular DNA (Gilbert and Cohen, 1987;  especially at low E1 concentrations (Bonne-Andrea et al., 1995; Yang et al., 1991 Yang et al., , 1991a . It has recently been demonstrated that E1 can efficiently drive multiple (Bonne-Andrea et al., 1995) . This suggests important contide used was 5GACGGAAAGAAGGAGCAAAGCG3. This oligonucleotide hybridizes to the opposite strand to trol mechanisms are active in the cell to maintain the tight control on copy number observed in latently transformed the one above; the underlined GAA encodes glutamic acid and replaces the alanine codon generated in the cells that are not observed in vitro.
E1 is phosphorylated at numerous sites that are not mutant above. Full-length wild-type and the two mutant fE1 were subcompletely defined (Lentz et al., 1993) . Phosphorylation is a common mechanism for activating and inactivating cloned into the BamHI site of the baculovirus transfer vector pVL1393 (Pharmingen). The mutations were also protein function. Kinases and phosphatases regulate many aspects of the cell cycle, including DNA replication.
incorporated into the full-length BPV genome by replacing the wild-type XmaI to EcoRI fragment of the plasmid We are analyzing the role of phosphorylation of E1 on its DNA replication activities. Here we identify serine 109 pMLBPV (Lusky and Botchan, 1984) , with the corresponding fragment from the mutant pGEMfE1 plasmids. Subas a target for phosphate addition in vivo and in vitro. Viral genomes carrying a serine to alanine mutation at cloning was by established procedures (Maniatis et al., 1982) . position 109 of E1 replicate more efficiently than the wildtype genome in a transient replication assay. In vitro DNA Cells and viruses binding activity of purified E1 is also modified by this mutation. When serine 109 is mutated to glutamic acid, Mouse C127 cells were grown and maintained in Dulreplication activity is reduced compared to wild-type. The becco's modified Eagle's medium (Gibco) supplemented implications for phosphorylation of E1 on BPV replication with 10% fetal bovine serum (JRH Biosciences), penicillin, are discussed. and streptomycin. Chinese hamster ovary (CHO) cells were cultured in F-12 medium supplemented with 10% MATERIALS AND METHODS fetal bovine serum, penicillin, and streptomycin. Culture of Spodoptera frugiperda Sf9 cells and their infection by DNA manipulations recombinant baculoviruses was as previously described The full-length E1 gene from BPV-1 was cloned by (Mohr et al., 1990; Summers and Smith, 1987) . Generation polymerase chain reaction (PCR) as described (Innis and of recombinant baculovirus expressing either wild-type Gelfand, 1990), using VENT Polymerase (New England or alanine mutant BPV E1 protein utilized the Pharmingen Biolabs) according to manufacturer's recommended Baculogold viral DNA in a lipofection protocol (Lipofectin, modifications. Primers used were 5f-E1 (5GCTCTA-Gibco BRL). Sf9 cells (3 1 10 6 ) were plated onto 60-GAGGATCCATGGACTACAAGGACGACGATGACAAGATmm dishes in Grace's medium with no supplements and GGCAAACGATAAAGGTAGC3) for the 5 end of E1 and allowed to adhere for 1 hr. A mixture of 0.2 mg Baculogold 3-E1 (5CCGGATCCGTCGACTCAATCAACTGCATTTGT-DNA, 1.7 mg recombinant DNA, and 40 ml medium was GTTTCTTGCGC3) for the 3 end of E1. Both ends of the added to 10 ml of Lipofectin in 25 ml of medium and PCR product can be digested by BamHI. The sequence incubated 15 min at room temperature. Medium was 5f-E1 incorporates nucleotides coding for methionine added to 1 ml, then added to cells, followed by incubation followed by the eight-amino-acid peptide recognized by for 12 hr at 27Њ, rocking the plates occasionally. The DNAthe anti-FLAG M2 monoclonal antibody (IBI) prior to the containing medium on the cells was replaced by 3 ml amino-terminal methionine of native E1. The full-length complete medium, and cells were incubated 4-5 days. E1 gene with the 5 FLAG coding sequence (f-E1) was Recombinant viruses were plaque purified (Summers cloned at the BamHI site of the phagemid vector and Smith, 1987) . pGEM3Zf(0) (Promega) to generate pGEMfE1. The cloned E1 gene was completely sequenced using the In vivo replication Sequenase Kit (USB) and found to be identical to the published sequence (Chen et al., 1982; Sanger et al., Analysis of transient replication of BPV DNA in mouse C127 cells was as described (Lentz et al., 1993) with the 1977, with corrections as published in Meyers et al., 1995) .
following modifications. Full-length wild-type or mutant BPV genomes were removed from the pML plasmid Mutant E1 genes were generated by oligonucleotidedirected mutagenesis using the protocol of Deng and background by digestion with BamHI. Digestion was analyzed by agarose gel electrophoresis to confirm that Nickoloff (1992). pGEMfE1 was used as the template. The oligonucleotide generating a serine to alanine mutaequivalent amounts of DNA were present in each sample. Replicated BPV DNA was isolated by modified HIRT tion at amino acid position 109 was 5CGCTTTGCTCCT-GCTTTCCG3. On the opposite strand, the underlined extraction on Days 2-6 following electroporation (Hirt, 1967) . After all samples were collected, the isopropanol-''C'' converts the TCA serine codon to a GCA alanine codon. Subsequently, the alanine mutant-containing precipitated DNA was collected by centrifugation, washed with 70% ethanol, and air-dried. DNA was displasmid was used as a template to convert position 109 to a glutamic acid by the same method. The oligonucleosolved in 10 ml water containing 20 mg/ml RNase A and incubated at 65Њ for 20 min. After cooling, 15 ml of restriccontinued for 3-4 hr. Labeled E1 was purified as described above. tion enzyme mix was added and the samples were incubated at 37Њ 12-16 hr. Restriction enzyme mixes conWestern blot tained manufacturer-supplied buffer, DpnI, and HindIII or EcoRI restriction enzymes. Digestion products were Western blot analysis of E1 protein was performed as separated on 0.8% agarose gels, covalently bound to described (Harlow and Lane, 1988) . Anti-FLAG mononylon membrane by capillary transfer and UV treatment, clonal antibody M2 (IBI) was used to detect E1 proteins and probed with a radiolabeled BPV-specific probe. The tagged at their amino terminus with the FLAG peptide. probe was generated by random-primed synthesis using the ''Prime-a-Gene'' Labeling System (Promega) acPhosphopeptide analysis cording to manufacturer's directions, using linear BPV Tryptic digestion and two-dimensional analysis of genome as a template. Blots were washed, dried, and phosphopeptides was performed essentially as deexposed to X-ray film (Amersham). As a control, blots scribed (Boyle et al., 1991) . Purified E1 proteins were were stripped by washing in boiling 0.5% sodium dodecyl precipitated with 10% trichloroacetic acid and washed sulfate and then reprobed with a random-primed fragwith ice-cold acetone. The proteins were oxidized in perment of pIL7 containing the rat cytochrome oxidase II formic acid, lyophilized, and then treated overnight with gene (Glaichenhaus and Cuzin, 1987) . Quantitation was 10 mg TPCK (tosylsulfonylphenylalanyl chloromethyl keperformed on a Fuji BAS 2000 phosphorimager system. tone)-trypsin in 0.05 M ammonium bicarbonate, pH 8.3. As a control, replication was also analyzed utilizing E1
The digested proteins were washed several times with and E2 expressed from heterologous promoters and a deionized water and lyophilized to dryness. Peptides BPV-origin containing plasmid in CHO cells as described were separated on cellulose thin-layer plates (Whatman) (Chiang et al., 1992b; Holt and Wilson, 1995) . E2 was by electrophoresis in the first dimension in pH 1.9 buffer expressed from the adenovirus major late promoter from (1794:156:50; deionized water:glacial acetic acid:formic plasmid pCG-E2 (a gift from V. Wilson); wild-type and acid) for 30 min at 1000 V. After the plates were dried, mutant fE1 were expressed from the SV40 early promoter peptides were separated in the second dimension from plasmid pSG5 (a gift of S. Khan). The target plasmid by chromatography in phosphochromatography buffer was pGEM (Promega) containing a 106-bp AluI fragment (94:75:63:19; n-butanol:deionized water:pyridine:glacial spanning nucleotides 7892 to 51 of the BPV genome. acetic acid). Plates were dried and exposed to X-ray film. One microgram of the target plasmid and 5 mg of each expression plasmid were used in each experiment.
In vitro phosphorylation of E1
Expression and purification of E1 Purified fE1 proteins were phosphorylated with protein kinase A (PKA, Promega) in a 15-ml reaction conOne hundred-to 200-ml suspension cultures of Sf9 taining 40 mM Tris -HCl, pH 7.4, 20 mM MgCl 2 , 0.2 cells were infected as described (Mohr et al., 1990) . At mM ATP, 2.5 mCi [g 32 P]ATP, 20 -25 U PKA, and 150 ng 48 hr p.i., cells were recovered by centrifugation at 1000 E1. E1 was similarly phosphorylated by protein kinase g for 5 min, rinsed with phosphate-buffered saline (PBS, C (PKC, Promega) in reactions containing 20 mM Maniatis et al., 1982) , and repelleted. Cell pellets were HEPES, pH 7.4, 1 mM DTT, 10 mM MgCl 2 , 200 mg/ml used directly or stored at 070Њ. Purification of E1 from phosphatidyl serine, 1 mM CaCl 2 , 0.1 mM ATP, 2.5 salt-washed nuclei was as previously described (Mohr mCi [g 32 P]ATP, 5 -10 ng PKC, and 150 ng E1 protein. et al., 1990 ). An immunoaffinity column was prepared Reaction products were analyzed by separation on 10% with 1-2 ml of FLAG M2 monoclonal antibody complexed denaturing polyacrylamide gels, transfer to nitrocelluto Sepharose (IBI) and used according to manufacturer's lose, and autoradiography. instructions. Bound E1 was eluted with 0.1 M glycineHCl, pH 3.0, or synthetic FLAG peptide (IBI). Fractions of ATPase assay acid eluted E1 were neutralized with 0.05 M Tris-HCl, pH 8.0, and then analyzed by polyacrylamide gel electroPurified fE1 (30-150 ng) was added to a reaction mix in a total reaction volume of 20 ml containing 50 mM phoresis. E1-containing fractions were pooled, concentrated by dialysis against solid sucrose, dialyzed into Tris-HCl, pH 7.5, 5 mM MgCl 2 , 1 mg BSA, 1 mg denatured salmon sperm DNA, and 5 mCi [g 32 P]ATP. Reactions storage buffer (50 mM Tris-HCl, pH 7.8, 1 mM EDTA, 1 mM dithiothreitol (DTT), 12.5 mM MgCl 2 , 100 mM KCl, were incubated at 30Њ for 10-120 min. One microliter of reaction was spotted onto a cellulose PEI plate (J. T. 0.3 M NaCl, 10% glycerol), aliquoted, and stored at 070Њ. For in vivo 32 P-labeled proteins, cells were incubated for Baker Inc.) and air-dried. Plates were developed in 0.75 M KH 2 PO 4 pH 3.5, air-dried, and exposed to X-ray film. 1 hr in phosphate-and serum-free Grace's medium at approximately 45 hr p.i. at 10 7 cells/ml. Then 100 mCi/ Reactions were quantitated on a phosphorimager. Alternatively, fE1 was immunoprecipitated from crude ml of [ 32 P]orthophosphate was added, and incubation nuclear salt-wash extracts using FLAG M2 monoclonal antibody and protein A-Sepharose beads, as described Consensus Protein Kinase A and Protein Kinase C Sites in below. After the beads were washed, ATPase reactions Papillomavirus E1 Proteins were performed as above directly with immune complexed fE1.
Origin binding
A modified immunoprecipitation procedure was used (Wilson and Ludes-Meyers, 1991) . Purified or crude E1 was prepared as described above. Sf9 cells infected with recombinant baculovirus expressing BPV L1 protein were used as a control for nonspecific binding of cellular or baculovirus proteins during immunoprecipitation. Radiolabeled origin-containing (ori / ) or origin-lacking (ori 0 ) DNA probes were generated by PCR, using primers labeled at their 5 ends by reaction with T4 polynucleotide kinase (Promega) and [g 32 P]ATP (Maniatis et al., 1982) . fE1 or fL1 protein was precipitated from solution by binding to FLAG M2 monoclonal antibody followed by binding to protein A-Sepharose beads (Sigma). Immune complexes were washed with 20 mM Tris-HCl, pH 8.0, 5 a Kennelly and Krebs (1991).
mM KCl, 1 mM MgCl 2 , 1 mM DTT, and 0.3 M NaCl, and b Meyers et al. (1995) .
then resuspended in 20 ml binding buffer containing 30
c HPV-5, -8, -12, -19, -20, -21, -25, -48, -50, -65 (Meyers et al., 1995 et al., 1993) . Other in vivo phosphates appear to incubated at 30ЊC, for 30 min. Unbound probe was be on serine residues; however, specific sites of serine washed from the immune complexes, which were then phosphorylation have not been identified. By sequence treated with 70 ml dissociation buffer (1% SDS, 50 mM homology to known target sequences (Kemp and Pear-EDTA, pH 8.0), for 15 min at 65Њ. Bound DNA was purified son, 1990; Kennelly and Krebs, 1991), we identified serine by phenol/chloroform extraction and ethanol precipita-109 as a putative site for phosphorylation by cAMP-detion, followed by separation on 5% polyacrylamide gels pendent protein kinase (PKA), as well as protein kinase in 11 TBE buffer (Maniatis et al., 1982) . The gels were C (PKC) ( Table 1) . A serine is present at a similar position dried and exposed to X-ray film and then quantitated on and context in many, but not all papillomavirus E1 proa phosphorimager. Immunoprecipitations were done in teins (Table 1) . duplicate, with one sample used for a control Western
To determine whether serine 109 can be a target for blot, described above.
phosphate addition on E1, we mutated the TCA codon of serine 109 to GCA, coding for alanine, which lacks the RESULTS phosphoacceptor hydroxyl group (E1S109A). The mutant E1 gene was used to generate a recombinant baculovi-E1, the major replication protein of the papillomavirus for synthesis and purification of mutant E1 protein. ruses, is capable of driving multiple rounds of DNA synBoth wild-type and mutant E1 proteins were expressed thesis from a given template molecule in vitro (Bonneand purified from insect cells infected with recombinant Andrea et al., 1995) . Replication of BPV DNA in latently baculoviruses. Wild-type or mutant E1 protein (150 ng) infected cells, however, is tightly regulated through the was phosphorylated in vitro using purified kinases. Reaccell cycle. The activity of the E1 protein is therefore likely tion products were analyzed by SDS-polyacrylamide gel to be modulated by cellular mechanisms during the electrophoresis, followed by transfer to a nitrocellulose course of a natural infection or during replication in tismembrane and autoradiography. As can be seen in Fig.  sue culture cells. E1 is known to be phosphorylated in 1A, E1 is efficiently labeled by PKA and PKC, while the vivo and in vitro (Lentz et al., 1993) ; no other protein S109A E1 protein is utilized as a substrate less efficiently modifications have been identified. We hypothesized that by both kinases. Autophosphorylation by both kinases phosphorylation of E1 may play a role in regulating BPV was also observed, as well as efficient labeling of an DNA replication in living cells.
unidentified component of the PKC reaction. The E1 E1 serine 109 is a phosphate acceptor site amino acid substitution resulted in a 70% reduction in counts incorporated by PKA, while PKC labeling was rePrevious work indicated that threonine 102 is a site for phosphate addition by the cdk28/cdc2 p34 kinase duced by 40%. Sequence analysis of the E1 protein re-serine 109 as a phosphoacceptor on the E1 protein both in vivo and in vitro.
In vivo replication of wild-type and mutant BPV genomes
Having determined the potential of serine 109 as a phosphoacceptor site, we analyzed the effect of a serine 109 to alanine mutation on replication of BPV DNA in vivo. A transient replication assay was used, measuring the accumulation of BPV DNA in cultured cells as the cells divide. The copy number of BPV genomes per cell is maintained at a relatively constant level by controlled replication of the BPV genomes during the S phase of the cell cycle. As cell density increases over time, the signal from BPV DNA increases proportionally in this assay.
Transient replication of wild-type BPV and BPV E1S109A is shown in Fig. 3A for a representative experiment. The mutant BPV genome consistently replicates to was consistent over five independent replication experiments using different DNA preparations. While we have shown that serine 109 is a target in veals several other putative target sites for both PKA and vivo and in vitro for phosphate addition, it is possible that PKC. Phosphorylation of one or more of these positions the replication phenotype of the mutant is the result of could account for the residual labeling of the S109A mua more general effect on the local structure of the E1 tant by these kinases in vitro. The membrane was probed protein. To test whether the observed increase in replicawith monoclonal antibody to the amino terminal tag on tion resulted from lack of phosphate addition, a serine the E1 proteins. The Western blot, shown in Fig. 1B , 109 to glutamic acid mutation was created in the E1 illustrates that equivalent amounts of E1 were present in each reaction. These results demonstrate that E1 serine 109 is a target site for PKA and PKC in vitro.
Wild-type and mutant E1 proteins were labeled in vivo with [ 32 P]orthophosphate and purified. Two-dimensional analysis of tryptic phosphopeptides revealed that wildtype E1 contains a major phosphopeptide only weakly utilized in the E1S109A mutant (Fig. 2 ). There were no other major differences in the phosphopeptide map between the wild-type and mutant E1 proteins. These experiments were done by infecting insect Sf9 cells with recombinant baculoviruses expressing the wild-type or mutant E1 proteins. While we were able to demonstrate a difference in the tryptic phosphopeptide map, it must gene, and this mutant was subcloned into the BPV gerect effect on replication functions of E1. To test this possibility, replication assays were performed in CHO nome. The negative charge at physiological pH of the glutamic acid side chain may mimic a constitutively phoscells using E1 and E2 expressed from heterologous promoters, along with a target plasmid containing the BPVphorylated serine side chain. In a transient replication assay, this mutant replicated less efficiently than ge-1 origin. In this system, E1 and E2 proteins and the replication origin sequences are the only BPV components nomes carrying the wild-type E1 gene (Fig. 4) . In the experiment shown, the mutant replicated to a level of present, eliminating indirect effects on other viral genes.
In several repetitions of this assay, inconsistent results 70% of that of wild-type. This result supports our conclusion that the replication phenotype observed is directly were obtained. In one experiment, there was no observable replication difference between wild-type and S109A related to phosphorylation of serine 109. Loss of the ability to add phosphate to serine 109 results in higher rates mutant E1. In other experiments, the mutant replicated several percent to 1.5-fold better than wild-type (data not of DNA replication, while a constitutive negative charge at this position reduces replication. Phosphorylation of shown). BPV efficiently transforms rodent cells. This phenotype E1 at serine 109 may therefore be involved in downregulating E1 activity in cycling cells.
is primarily due to activity of the products of the E5, E6, and E7 genes (Howley, 1990) . There has been some E1 has been shown to modulate E2-mediated transactivation of the BPV-1 P 89 promoter, responsible for excontroversy over whether mutations in the E1 gene affect the transformation efficiency of BPV. Reexamination of pression of the E6 and E7 transforming genes (Le Moal et al., 1994; Sandler et al., 1993; Vande Pol et al., 1995) .
E1 mutants from several labs indicates that E1 mutations Therefore, it is possible that the replication phenotype generally result in lower transformation efficiency observed for the S109A mutant E1 is an indirect effect (Chiang et al., 1992a) . This phenotype is hypothesized to resulting from transcription modulation rather than a diresult from loss of viral DNA due to replication defects. The S109A BPV genome transforms cells to the same level as wild-type, as shown in Table 2 . Since mutant viral DNA replication is higher than that of wild-type, it is not surprising that transformation efficiency is not significantly reduced. This result also suggests that the increased level of DNA replication observed for the mutant genome is not the result of differences in electroporation efficiency.
ATPase activity of wild-type and mutant proteins
We next wished to determine the activity or activities of the mutant E1 protein that was responsible for the replication phenotype. We examined purified wild-type and mutant E1 proteins for several specific E1 activities in vitro.
E1 is a DNA-dependent ATPase (MacPherson et al., 1994) . The hydrolysis of ATP likely provides a source of energy for enzymatic unwinding of template DNA by E1 helicase activity. Wild-type or mutant E1 proteins were immunoprecipitated from nuclear extracts, washed, and analyzed for their ability to hydrolyze [g 32 P]ATP to free phosphate. ATP hydrolysis was analyzed by chromatography of reaction products and quantitated on a phosphorimager. In several independent experiments using different protein preparations, there was no major difference in the ATPase activity of the mutant E1 protein compared to wild-type (data not shown). These experiments were done using a range of E1 concentrations and reaction times. Alteration of ATPase enzyme activity Replication origin binding activity of unbound DNA. Bound DNA was purified and separated on 5% polyacrylamide gels which were dried and exposed to X-ray film. ori served 18-bp inverted repeat at or near the site where template melting and DNA synthesis are initiated (Holt et al., 1994) . Recognition and binding to this origin seor ori 0 DNA. The immunoprecipitation reactions were quence are intrinsic properties of the E1 protein, although performed in triplicate, with two sets run directly on denain vivo E1 binding to the origin is believed to be facilitated turing polyacrylamide gels for analysis of E1 proteins. by interaction with the viral E2 protein and an adjacent Both Coomassie staining (not shown) and Western blot-E2 binding site Mohr et al., 1990; ting (Fig. 5B) demonstrate that there are no major differ- Yang et al., 1991) .
ences in the amount of E1 present in each DNA binding Wild-type and mutant E1 proteins were immunoprecipireaction. This suggests that differences in DNA binding tated from Sf9 cell nuclear extracts. Immune complexes between the two proteins cannot be accounted for by were washed and then incubated with radiolabeled ori / differences in expression, antibody binding, or protein and ori 0 DNA fragments. The immune complexes were stability through the purification protocol. In the experiagain washed to remove unbound DNA fragments, folment shown, there may be more wild-type E1 protein than lowed by extraction of bound DNA from the immune commutant, making the differences in DNA binding efficiency plexes. The recovered DNA was analyzed by polyacryleven more striking. amide gel electrophoresis, and the results are shown in DNA binding activity of the two E1 proteins was quanti- Fig. 5A . E1 with the serine to alanine substitution was tated on a phosphorimager. In five independent expericonsistently able to bind more DNA than wild-type E1.
ments, S109A was found to bind from 1.6-to greater than Wild-type E1 bound almost exclusively ori / DNA, while 8-fold more ori / DNA than wild-type. Interestingly, this the S109A mutant E1 bound both ori / and significant ratio equals or exceeds the differences observed in repliamounts of ori 0 DNA. Extracts from cells expressing BPV L1 protein as a negative control did not bind either ori / cation efficiency in mouse C127 cells. Therefore, the in-creased binding efficiency of the mutant E1 protein could could recognize this site as a target. We have shown that in vitro, both PKA and PKC utilize serine 109 as a account for the replication phenotype of the mutant.
target. Furthermore, a mutation in which the wild-type serine in converted to glutamic acid has a reduced repli-DISCUSSION cation phenotype compared to the wild-type protein.
Whereas alanine prevents phosphate addition by removPapillomaviruses provide an attractive model system for analyzing control of DNA replication in eukaryotic ing the phosphoacceptor hydroxyl group, glutamic acid has a negative charge that may mimic a constitutively cells. During a latent period in the course of a natural infection, viral DNA is maintained as an episome at a phosphorylated serine. The striking difference in the phenotypes of the two mutants lends support to our concluconstant copy number. This mode of viral DNA replication is mimicked in cells grown transiently in monolayer sion that the presence or absence of phosphate at position 109 is directly responsible for the replication phenoculture in the laboratory, as well as in stably transformed cell lines. This is in contrast to most viruses in permissive type of the viral genomes. It is unlikely that there are major changes in the overall cells which undergo a lytic pathway, including uncontrolled replication to high copy number. High-copy amplistructure of the mutant E1 protein, since another intrinsic activity of the protein, enzymatic hydrolysis of ATP, is fication of papillomavirus DNA is restricted to terminally differentiated keratinocytes, where changes in DNA repliunaffected. Furthermore, the quantities of mutant E1 protein purified from crude nuclear extracts match that of cation and gene expression result in assembly of infectious progeny virions. Undifferentiated cells may contain wild-type, suggesting that there are no major differences in the overall stability of the protein. The promoters for a factor(s) that actively restricts viral DNA replication to low-copy-number maintenance or may be missing a facexpression of E1 and other BPV proteins in the viral genome are weak. We are unable to detect E1 in transiently tor(s) required for vegetative DNA amplification.
We are investigating the hypothesis that kinases and/ transfected cells. We cannot rule out the possibility that expression of the mutant E1 protein from the BPV geor phosphatases play an important role in regulating papillomavirus DNA replication by altering the phosphate nome is altered in some way that would account for the observed replication phenotype. While it is not likely, we content of viral replication proteins. There are well-characterized structural and functional similarities between cannot formally rule out the possibility that the replication defects we have observed are not an indirect result of papillomavirus E1 proteins and the large tumor (T) antigen of simian virus 40 (SV40). SV40 large T antigen is affecting the transcriptional regulatory properties of E1. Our experiments to analyze replication function in the regulated both positively and negatively by phosphorylation. Enzymatic removal of phosphate from serine resiabsence of viral genes other than E1 and E2 were inconclusive. dues or mutation of phosphoacceptor serines of large T antigen increases site-specific DNA binding activity and
We do not believe the presence of the FLAG sequence at the amino terminus of the purified E1 proteins interenhances DNA replication in vivo and in vitro (Fanning, 1992 , and references therein). On the other hand, phosferes with the interpretation of our experimental results. BPV-1 E1 with a nine-amino-acid tag (EE) efficiently repliphorylation of threonine 124 is required for efficient DNA binding by large T antigen and initiation of DNA replicacates origin-containing DNA in vitro (Yang et al., 1991) . A direct comparison of untagged and FLAG-tagged human tion. It has been also demonstrated that mutation of phosphorylation sites in the BPV E2 protein, which plays papillomavirus type 11 (HPV-11) E1 in an in vivo transient replication assay demonstrated that there were no funcan auxiliary role in viral DNA replication, increases DNA replication and stable copy number (McBride and Howtional differences between the two proteins (Grodberg et al., personal communication). ley, 1991) . Since E1 plays a more direct role in replication, we have begun analyzing the activity of E1 phosphorylaWe have shown that the mutant E1 protein has increased affinity for the replication origin in DNA binding tion site mutants. We have demonstrated that alanine substitution of an E1 phosphate acceptor site at serine assays. Several groups have mapped the DNA binding domain of E1 using deletion mutagenesis and found this 109 alters the replication phenotype of the virus in transient replication assays, resulting in an increase in viral activity to reside in amino-terminal half of the protein.
The amino-terminal boundary of the DNA binding domain DNA replication. Furthermore, the effect on DNA replication can be accounted for by an increase in the ability maps between residues 122 and 162 (Sarafi and McBride, 1995; Thorner et al., 1993 ; Leng and Wilson, of the mutant E1 protein to bind to the replication origin on the viral DNA.
unpublished results). Serine 109 falls outside of this functional domain. Our DNA binding assays are carried out Several lines of evidence support the hypothesis that loss of phosphorylation is responsible for the replication in the absence of the E2 protein, so modified interaction with E2 cannot account for our in vitro observations. phenotype of the mutant. We have shown that serine 109 is a phosphoacceptor in vivo. The sequences surThere may be regions, including serine 109, that are not required for DNA binding, but play a role in modulating rounding serine 109 suggest that either PKA and/or PKC
